Literature DB >> 35031330

Reinforcement sensitivity predicts affective psychopathology via emotion regulation: Cross-sectional, longitudinal and quasi-experimental evidence.

Benjamin A Katz1, Iftah Yovel2.   

Abstract

The current article presents a model wherein reinforcement sensitivity predicts depression and anxiety via trait preferences for concomitant emotion regulation strategies. In Study 1 (N = 593), BAS sensitivity positively predicted reappraisal and BIS sensitivity negatively predicted it. Reappraisal then negatively predicted depression. BIS sensitivity also predicted rumination, which predicted both depression and anxiety. Study 2a confirmed the model developed in Study 1 with an independent sample (N = 513) and examined the relationships longitudinally. While the cross-sectional relationships were generally maintained, reinforcement sensitivity did not predict reappraisal. In Study 2b, participants (N = 218) were assessed a third time one year later, at the onset of the COVID-19 pandemic. During this stressful time, BAS sensitivity did longitudinally predict reappraisal. These studies highlight the role of emotion regulation in mediating the relationship between reinforcement sensitivity and affective pathology, particularly during times of high stress.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Internalizing Disorders; Longitudinal Study; Reappraisal; Reinforcement Sensitivity; Rumination

Mesh:

Year:  2022        PMID: 35031330     DOI: 10.1016/j.jad.2022.01.017

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  2 in total

1.  Temperamental Change in Adolescence and Its Predictive Role on Anxious Symptomatology.

Authors:  Maria Balle; Aina Fiol-Veny; Alejandro de la Torre-Luque; Jordi Llabres; Xavier Bornas
Journal:  Behav Sci (Basel)       Date:  2022-06-16

2.  Mood symptoms predict COVID-19 pandemic distress but not vice versa: An 18-month longitudinal study.

Authors:  Benjamin A Katz; Iftah Yovel
Journal:  PLoS One       Date:  2022-09-02       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.